Inspection Record

MSN Life Sciences Private Limited, Unit II — FDA 483 Findings

US FDAInspected 2024-09-13Published 2026-08-05 4 findingsDeviation, CAPA, and investigationEquipment and facility

View the regulator's official source The source document is always the basis for judgement.

Findings

1Deviation, CAPA, and investigation

Your quality unit failed to perform one of it's core responsibilities to ensure that critical deviations are investigated and resolved.

2Equipment and facility

Your production areas fail to provide adequate washing facilities for personnel.

3Deviation, CAPA, and investigation

Your quality unit failed to review all critical deviations or non-conformances and related investigations for all API products.

4Deviation, CAPA, and investigation

Your firm failed to thoroughly investigate critical deviations and/or the failure(s) of a batch to meet specifications.

About this record

Extracted automatically from the document US FDA published on 2026-08-05. The source is available at the link above.

This is a record of that moment. Inspection findings are usually followed by the company's response and corrective action, but this page does not know how that turned out. Do not read it as the current state; check the regulator's official announcements for the latest status.

Translation and classification are automated and may differ in nuance from the source.

MSN Life Sciences Private Limited, Unit II company profile — full history US FDA documents, 2026 Go to Findings search